This technological breakthrough, developed by a team from the Itaca Institute of the UPV, the company Corify Care, and the Gregorio Marañón Hospital, has achieved publication in two of the most prestigious journals in the field: Heart Rhythm and Europace. These publications position Acorys technology as one of the most precise solutions for mapping both atrial and ventricular arrhythmias in a single heartbeat.
Currently, arrhythmia mapping is often a slow process that typically requires inducing unstable rhythms in the patient or relying on previously obtained radiological images. Corify Care's technology eliminates this need by capturing cardiac electrical activity globally and instantly. This provides crucial and actionable information even before ablation begins.
“"Time and predictability are the most valuable assets in an electrophysiology lab. These publications demonstrate that we can offer physicians a complete view from the very first moment, without waiting. It's a paradigm shift: moving from 'mapping' to 'knowing'."
In the published studies, medical and research staff from the Institut Clínic Cardiovascular of Hospital Clínic de Barcelona, the Institut d'Investigacions Biomèdiques August Pi i Sunyer, the Biomedical Research Networking Center on Cardiovascular Diseases, the Biomedical Research Networking Center on Mental Health, the Faculty of Medicine in Berlin, the University Hospital of Saint-Étienne, and the German Cardiovascular Research Center participated alongside the UPV and Corify Care teams.
The Niavas study, published in Heart Rhythm, demonstrates that the technology successfully identifies the arrhythmogenic substrate of Ventricular Tachycardia while the patient is in normal sinus rhythm, eliminating the need to induce hemodynamically unstable arrhythmias. Simultaneously, the study in Europace validates the 'imageless' approach for specific atrial arrhythmias, generating precise activation maps of the entire cavity without the need for prior CT or MRI scans.
“"We are eliminating uncertainty in complex ablations. For the first time, specialists can visualize arrhythmia circuits instantly—without relying on external images or increasing procedural risk—allowing for targeted and safe interventions from the outset."
This clinical impact directly translates into improved patient care. The mapping system complies with European regulations (CE marking) and U.S. regulatory requirements, having recently obtained FDA 510(k) clearance. Corify Care will present new clinical data from these studies, along with 12 other scientific presentations, at the Heart Rhythm Society (HRS) 2026 congress, to be held in Chicago from Thursday, April 23 to Sunday, April 26.
